Managing Editor’s Message: If We Build it, Will They Even Notice?
Clinical Researcher—January 2018 (Volume 32, Issue 1) MANAGING EDITOR’S MESSAGE Gary W. Cramer [DOI: 10.14524/CR-18-4005] Although it does not appear in these exact words in any of the articles or columns making up this issue, the sentiment that kept coming to my mind as I collected and edited them was the infamous (albeit paraphrased) quote […] Details
Special Advertising Supplement: Barnett: Are You a QUALIFIED Clinical Research Professional?
SPECIAL ADVERTISING SUPPLEMENT The term qualified is the guiding standard for a clinical research professional’s work assignments.1 Webster’s dictionary defines “qualified” as “being ‘competent’ to perform the assigned work, duty, function, or task.” Given our healthcare industry roots, competency-based training for clinical research professionals is based on the model used to train healthcare professionals (e.g., […] Details
Special Advertising Supplement: FXM Research: It’s Not Just Clinical Research! It’s Clinical Research Excellence…Sustained!
SPECIAL ADVERTISING SUPPLEMENT Founded in 2000, FXM Research is a privately owned and operated Clinical Research Site that conducts Phase ll, lll, and lV clinical research trials specializing in Dermatology. Throughout the years, our ability to deliver aggressive, time-bound enrollment goals, while providing trustworthy data to pharmaceutical companies and contract research organizations (CROs), has earned […] Details
PI Corner: Patient Recruitment and Engagement: One Size Does Not Fit All
Clinical Researcher—January 2018 (Volume 32, Issue 1) PI CORNER Elisa Cascade, MBA; Claire Sears, DPhil [DOI: 10.14524/CR-18-4000] Patient recruitment and retention difficulties commonly lead to delays of one to six months for 86% of clinical trials, with the remaining 14% experiencing even longer delays.1 According to the Clinical Trials Transformation Initiative (CTTI), the public-private partnership […] Details
Demystifying Devices: All is Not Lost: Minimizing Lost-to-Follow-Up Subjects in Long-Term Medical Device Studies
Clinical Researcher—January 2018 (Volume 32, Issue 1) DEMYSTIFYING DEVICES Eric Distad; Laura Eaton [DOI: 10.14524/CR-18-4007] As medical device technology is becoming more and more sophisticated, the need for long-term follow-up in postmarket or late-phase studies is becoming the norm. Regulatory agencies are seeking data on longer-term safety effects—sometimes for the life of the product or […] Details
Careers—Passing it On: A Q&A with Jennifer Visich, PhD
Clinical Researcher—January 2018 (Volume 32, Issue 1) CAREERS—PASSING IT ON Gary W. Cramer [DOI: 10.14524/CR-18-4004] In this installment of our careers-focused Q&A series, we are pleased to hear from Jennifer Visich, PhD, an Executive Director with Certara Strategic Consulting, a subsidiary of Certara, L.P. Visich lives in Boulder, Colo. Q: What’s the average “day in […] Details